Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN
- PMID: 9633699
- DOI: 10.1212/wnl.50.6.1594
Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN
Abstract
Objective: The authors sought to determine acute ambulatory- and hospital-billed charges for the Olmsted County, Minnesota Multiple Sclerosis (MS) Disability Prevalence Cohort and compare them to those incurred by the general population.
Methods: Billed charges for 155 people with clinically definite or laboratory-supported MS were compared with those of age- and gender-matched non-MS controls. Billing data, including all inpatient and outpatient acute and rehabilitative medical care charges over a 5-year period surrounding a December 1, 1991 prevalence date, were analyzed. Data were correlated with level of disability using the Minimal Record of Disability for MS.
Results: Median total annual billed charges for most individuals with MS, including those with less severe ($1,277) and relapsing-remitting illness ($1,348), did not differ from those for controls ($1,327, p=0.075). Only those with severe MS (22.6%) had median annual medical charges higher than controls ($5,440, p < 0.001). Male patients with MS had higher median annual total charges ($2,353) than male controls ($762, p=0.003). Total charges for female patients with MS ($1,440) were not different from those for female controls ($1469). Median annual outpatient charges were 15% more for the MS group ($1,418) than for controls ($1,231). Patients with MS had a mean of 0.2 hospital admissions annually compared with 0.1 annual admissions per control patient. Among variables collected on persons with MS, the Expanded Disability Status Scale was the strongest predictor of level of charges (p < 0.001).
Conclusion: Acute ambulatory- and hospital-billed charges for most patients with MS do not differ from those of the general population.
Comment in
-
The use and cost of medical resources: what will we pay for neurologic health?Neurology. 1998 Jun;50(6):1528-9. doi: 10.1212/wnl.50.6.1528. Neurology. 1998. PMID: 9633689 No abstract available.
-
Health care utilization in MS.Neurology. 1999 Sep 11;53(4):892-3. doi: 10.1212/wnl.53.4.892-a. Neurology. 1999. PMID: 10489070 No abstract available.
Similar articles
-
Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota.Neurology. 1994 Jan;44(1):28-33. doi: 10.1212/wnl.44.1.28. Neurology. 1994. PMID: 8290086
-
Impact on healthcare resource utilization of multiple sclerosis in Spain.BMC Health Serv Res. 2017 Dec 29;17(1):854. doi: 10.1186/s12913-017-2807-x. BMC Health Serv Res. 2017. PMID: 29284493 Free PMC article.
-
Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium).J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):444-50. doi: 10.1136/jnnp.64.4.444. J Neurol Neurosurg Psychiatry. 1998. PMID: 9576533 Free PMC article.
-
Disability profile of MS did not change over 10 years in a population-based prevalence cohort.Neurology. 2004 Feb 24;62(4):601-6. doi: 10.1212/wnl.62.4.601. Neurology. 2004. PMID: 14981177 Review.
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
Cited by
-
Hospitalization rates and discharge status in multiple sclerosis.Mult Scler Int. 2013;2013:436929. doi: 10.1155/2013/436929. Epub 2013 May 13. Mult Scler Int. 2013. PMID: 23766908 Free PMC article.
-
Long-term epidemiology of multiple sclerosis in the Northern Seville District.Acta Neurol Scand. 2015 Aug;132(2):111-7. doi: 10.1111/ane.12363. Epub 2015 Feb 4. Acta Neurol Scand. 2015. PMID: 25649860 Free PMC article.
-
Home based management in multiple sclerosis: results of a randomised controlled trial.J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):250-5. doi: 10.1136/jnnp.73.3.250. J Neurol Neurosurg Psychiatry. 2002. PMID: 12185154 Free PMC article. Clinical Trial.
-
Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries.Clinicoecon Outcomes Res. 2019 Jan 7;11:61-71. doi: 10.2147/CEOR.S179903. eCollection 2019. Clinicoecon Outcomes Res. 2019. PMID: 30662276 Free PMC article.
-
Assessing cost-effectiveness in the management of multiple sclerosis.Clinicoecon Outcomes Res. 2009;1:61-78. doi: 10.2147/ceor.s4225. Epub 2009 Nov 18. Clinicoecon Outcomes Res. 2009. PMID: 21935308 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical